SEARCH

SEARCH BY CITATION

References

  • Abu El-Asrar AM, Dralands L, Missotten L & Geboes K (2007). Expression of antiapoptotic and proapoptotic molecules in diabetic retinas. Eye 21, 238245.
  • Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA & Geboes K (2004). Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 45, 27602766.
  • Aizu Y, Oyanagi K, Hu J & Nakagawa H (2002). Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology 22, 161170.
  • Ali TK, Matragoon S, Pillai BA, Liou GI & El-Remessy AB (2008). Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57, 889898.
  • Ambati J, Chalam KV, Chawla DK, D'Angio CT, Guillet EG, Rose SJ, Vanderlinde RE & Ambati BK (1997). Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 115, 11611166.
  • Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A & Lorenzi M (2003). A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52, 506511.
  • Bailey CC & Sparrow JM (2001). Visual symptomatology in patients with sight-threatening diabetic retinopathy. Diabet Med 18, 883888.
  • Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW & Bronson SK (2005). The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46, 22102218.
  • Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG & Gardner TW (1998). Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102, 783791.
  • Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, Horig H, Hudson BI, Qu W, Weinberg AD, Yan SF & Schmidt AM (2005). The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 46, 29162924.
  • Bloodworth JM Jr (1962). Diabetic retinopathy. Diabetes 11, 122.
  • Chaturvedi N (2000). Modulation of the renin-angiotensin system and retinopathy. Heart 84 (Suppl. 1), i2931: discussion i50.
  • Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z & Fuller JH (1998). Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial Lisinopril Insulin-Dependent Diabetes Mellitus. Lancet 351, 2831.
  • Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS & Chung SK (2005). Aldose reductase deficiency prevents diabetes-induced blood–retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54, 31193125.
  • Chihara E, Matsuoka T, Ogura Y & Matsumura M (1993). Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology 100, 11471151.
  • Chihara E & Zhang S (1998). Analysis of diabetic optic neuropathy with a topographic laser scanning system. Nippon Ganka Gakkai Zasshi 102, 431435.
  • Della Sala S, Bertoni G, Somazzi L, Stubbe F & Wilkins AJ (1985). Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. Br J Ophthalmol 69, 136142.
  • Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329, 977986.
  • Dong CJ, Agey P & Hare WA (2004). Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis Neurosci 21, 533543.
  • El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB & Liou GI (2006). Neuroprotective and blood–retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168, 235244.
  • El-Remessy AB, Bartoli M, Platt DH, Fulton D & Caldwell RB (2005). Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118, 243252.
  • El-Remessy AB, Khalil IE, Matragoon S, Abou-Mohamed G, Tsai NJ, Roon P, Caldwell RB, Caldwell RW, Green K & Liou GI (2003). Neuroprotective effect of (–)D9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 163, 19972008.
  • Engerman RL & Kern TS (1987). Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36, 808812.
  • Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS & Chen DF (2005). Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46, 42814287.
  • Gastinger MJ, Barber AJ, Khin SA, McRill CS, Gardner TW & Marshak DW (2001). Abnormal centrifugal axons in streptozotocin-diabetic rat retinas. Invest Ophthalmol Vis Sci 42, 26792685.
  • Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK & Barber AJ (2008). Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2Akita diabetic mice. Invest Ophthalmol Vis Sci 49, 26352642.
  • Gastinger MJ, Singh RS & Barber AJ (2006). Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 47, 31433150.
  • Hammes H-P, Federoff HJ & Brownlee M (1995). Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1, 527534.
  • Hancock HA & Kraft TW (2004). Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 45, 10021008.
  • Ino-Ue M, Ohgiya N & Yamamoto M (1998a). Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats. Brain Res 800, 319322.
  • Ino-ue M, Yokogawa H, Yamamoto M, Naka H & Kuriyama H (1998b). Structural impairments in optic nerve of diabetic rats ameliorated with the aldose reductase inhibitor. Exp Eye Res 66, 397401.
  • Ino-ue M, Zhang L, Naka H, Kuriyama H & Yamamoto M (2000). Polyol metabolism of retrograde axonal transport in diabetic rat large optic nerve fiber. Invest Ophthalmol Vis Sci 41, 40554058.
  • Juen S & Kieselbach GF (1990). Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol 108, 372375.
  • Kamijo M, Cherian PV & Sima AAF (1993). The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W rat. Diabetologia 36, 893898.
  • Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA & Bingaman DP (2007). Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56, 373379.
  • Kerrigan LA, Zack DJ, Quigley HA, Smith SD & Pease ME (1997). TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 115, 10311035.
  • Kowluru RA, Engerman RL, Case GL & Kern TS (2001). Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 38, 385390.
  • Kowluru RA & Koppolu P (2002). Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic Res 36, 993999.
  • Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW & Levison SW (2005). Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54, 15591565.
  • Kusari J, Zhou S, Padillo E, Clarke KG & Gil DW (2007). Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 48, 51525159.
  • Kusner LL, Sarthy VP & Mohr S (2004). Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest Ophthalmol Vis Sci 45, 15531561.
  • Layton CJ, Safa R & Osborne NN (2007). Oscillatory potentials and the b-wave: partial masking and interdependence in dark adaptation and diabetes in the rat. Graefes Arch Clin Exp Ophthalmol 245, 13351345.
  • Li Q & Puro DG (2002). Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci 43, 31093116.
  • Li Q, Zemel E, Miller B & Perlman I (2002). Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res 74, 615625.
  • Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D & Strother JM (1998). Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 47, 815820.
  • Lieth E, Gardner TW, Barber AJ & Antonetti DA (2000). Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28, 38.
  • Lopes De Faria JM, Katsumi O, Cagliero E, Nathan D & Hirose T (2001). Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 239, 643648.
  • Lopes De Faria JM, Russ H & Costa VP (2002). Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol 86, 725728.
  • Martin PM, Roon P, Van Ells TK, Ganapathy V & Smith SB (2004). Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45, 33303336.
  • Meyer-Rusenberg B, Pavlidis M, Stupp T & Thanos S (2007). Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy. Graefes Arch Clin Exp Ophthalmol 245, 10091018.
  • Mohr S, Tang J & Kern TS (2002). Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51, 11721179.
  • Ning X, Baoyu Q, Yuzhen L, Shuli S, Reed E & Li QQ (2004). Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. Int J Mol Med 13, 8792.
  • Oshitari T, Yamamoto S, Hata N & Roy S (2008). Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy. Br J Ophthalmol 92, 552556.
  • Ozdek S, Lonneville YH, Onol M, Yetkin I & Hasanreisoglu BB (2002). Assessment of nerve fiber layer in diabetic patients with scanning laser polarimetry. Eye 16, 761765.
  • Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH & Oh SJ (2003). Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46, 12601268.
  • Phipps JA, Yee P, Fletcher EL & Vingrys AJ (2006). Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation. Invest Ophthalmol Vis Sci 47, 31873194.
  • Puro DG (2002). Diabetes-induced dysfunction of retinal Muller cells. Trans Am Ophthalmol Soc 100, 339352.
  • Qin Y, Xu G & Wang W (2006). Dendritic abnormalities in retinal ganglion cells of three-month diabetic rats. Curr Eye Res 31, 967974.
  • Ramsey DJ, Ripps H & Qian H (2006). An electrophysiological study of retinal function in the diabetic female rat. Invest Ophthalmol Vis Sci 47, 51165124.
  • Sakai H, Tani Y, Shirasawa E, Shirabo Y & Kawasaki K (1995). Development of elecrtoretinographic alterations in streptozotocin-induced diabetes in rats. Opththalmic Res 27, 5763.
  • Scott TM, Foote J, Peat B & Galway G (1986). Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin. J Anat 144, 145152.
  • Seigel GM, Lupien SB, Campbell LM & Ishii DN (2006). Systemic IGF-I treatment inhibits cell death in diabetic rat retina. J Diabetes Complications 20, 196204.
  • Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H & Takei N (2004). Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53, 24122419.
  • Shinoda K, Rejdak R, Schuettauf F, Blatsios G, Volker M, Tanimoto N, Olcay T, Gekeler F, Lehaci C, Naskar R, Zagorski Z & Zrenner E (2007). Early electroretinographic features of streptozotocin-induced diabetic retinopathy. Clin Experiment Ophthalmol 35, 847854.
  • Shirao Y & Kawasaki K (1998). Electrical responses from diabetic retina. Prog Retin Eye Res 17, 5976.
  • Sima AA, Zhang WX, Cherian PV & Chakrabarti S (1992). Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia 35, 602607.
  • Simonsen SE (1980). The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh) 58, 865878.
  • Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M & Senior B (1985). Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 103, 5154.
  • Takahashi H, Goto T, Shoji T, Tanito M, Park M & Chihara E (2006). Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. Am J Ophthalmol 142, 8894.
  • Tzekov R & Arden GB (1999). The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44, 5360.
  • UK Prospective Diabetes Study Group. (1998a). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 317, 703713.
  • UK Prospective Diabetes Study Group. (1998b). Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39. BMJ 317, 713720.
  • Vincent JA & Mohr S (2007). Inhibition of caspase-1/interleukin-1α signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 56, 224230.
  • Wachtmeister L (1998). Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17, 485521.
  • Wolter JR (1961). Diabetic retinopathy. Am J Ophthalmol 51, 11231141.
  • Zeng XX, Ng YK & Ling EA (2000). Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 17, 463471.
  • Zhang L, Inoue M, Dong K & Yamamoto M (1998). Alterations in retrograde axonal transport in optic nerve of type I and type II diabetic rats. Kobe J Med Sci 44, 205215.
  • Zhang L, Ino-Ue M, Dong K & Yamamoto M (2000). Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. Curr Eye Res 20, 131136.
  • Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W & Xu GT (2008). Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49, 732742.
  • Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Ball S, Berkowitz BA & Kern TS (2007a). Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50, 19871996.
  • Zheng L, Howell SJ, Hatala DA, Huang K & Kern TS (2007b). Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56, 337345.